The planning stage is critical to the success of any clinical trial. It sets expectations for how your team will work together to collect data, monitor results, protect human subjects and much more.
In effect, it sets the standards for your entire trial, so it’s essential to get it right from the start. However, the planning stage is most often when progress stalls before it even begins. Clinical professionals encounter a number of hurdles that can slow momentum, delay approval or even compromise the integrity of the study if they aren’t addressed.
Here are five of the most common hurdles your team is likely to face when planning a clinical trial and how to overcome them.
As you plan your trial, you will inevitably encounter some challenges, but they don’t have to derail your study. IMARC’s team of clinical research professionals can bring independent oversight and expertise to any clinical trial and provide recommendations to enhance the effectiveness of your people and processes.
Our team can help you devise the most effective strategy for your study, determine key milestones and identify opportunities to increase efficiency without compromising data integrity.
IMARC brings order to the chaos, simplifying difficult processes and ensuring compliance at every stage. Our team of clinical research experts works closely with yours to assess your current processes, advise you on best practices and ultimately, earn FDA approval. We have nearly two decades of experience working with national and global medical device trials, assisting with everything from monitoring and auditing to training and consulting. Due to popular demand, we’ve recently expanded our services to include project management, safety monitoring and site support.
Though we can step in to assist at any stage in your trial, our team offers the most value when we are involved from start to finish. In the early clinical planning stage, we can ensure your site is using appropriate protocol to comply with regulations and mitigate risks.
To learn more, contact us today.